Company intelligence / Profile preview

Polyphenolics

(Central Valley) *likely Modesto or Lodi area based on parent company locations*, California, USAphenol-explorer.eu ↗

Ownership: Private
Development stage: Commercial

Overview

Polyphenolics has developed patented grape seed extract ingredients with clinically demonstrated benefits for blood pressure and blood sugar management. Their MegaNatural® line is supported by human clinical trials showing efficacy in these areas. The company emphasizes traceability, purity, safety testing, and vertical integration from vineyard to finished ingredient.

Therapeutic areas: OtherCardiovascularEndocrinology
Modalities: Botanical extracts (grape seed polyphenols)Small molecules/natural products derived from grape seeds
Industry: Food & Nutrition

Drug pipeline

1 asset

apple polyphenol

Commercial

Indications: Weight management, Metabolic health

Partnerships

Not specified; works closely with supplement manufacturers/formulators worldwide.

Beyond the preview

Go deeper on Polyphenolics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyphenolics.

Explore the full profile